chr1-167765685-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003953.6(MPZL1):c.194C>T(p.Thr65Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003953.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZL1 | NM_003953.6 | c.194C>T | p.Thr65Met | missense_variant | 2/6 | ENST00000359523.7 | NP_003944.1 | |
MPZL1 | NM_024569.5 | c.194C>T | p.Thr65Met | missense_variant | 2/5 | NP_078845.3 | ||
MPZL1 | NM_001146191.2 | c.194C>T | p.Thr65Met | missense_variant | 2/3 | NP_001139663.1 | ||
MPZL1 | XM_047433610.1 | c.-179C>T | 5_prime_UTR_variant | 3/7 | XP_047289566.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPZL1 | ENST00000359523.7 | c.194C>T | p.Thr65Met | missense_variant | 2/6 | 1 | NM_003953.6 | ENSP00000352513 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250560Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135446
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461024Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726832
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.194C>T (p.T65M) alteration is located in exon 2 (coding exon 2) of the MPZL1 gene. This alteration results from a C to T substitution at nucleotide position 194, causing the threonine (T) at amino acid position 65 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at